2014

1. Osteoprotegerin correlates with disease activity and endothelial activation in non-diabetic ankylosing spondylitis patients undergoing TNF-α antagonist therapy

   Clinical and Experimental Rheumatology, Vol. 32, Núm. 5, pp. 640-646

2. Patients with ankylosing spondylitis and low disease activity because of anti-TNF-Alpha therapy have higher TRAIL levels than controls: A potential compensatory effect

   Mediators of Inflammation, Vol. 2014